The selective downregulation of IFNLR1 expression in cancer cells could be seen as an immune escape mechanism evolved during cancer development which allows cancer cells to secrete IFNλ to support immunomodulation of the tumor microenvironment while avoiding being affected themselves. This evidence concerns the gene IFNLR1 and cancer.